INTRODUCTION
I n 1931 Bischoff and Maxwell (1) tested the effects of prolan, estrin, and placental and pituitary gonadotropic extracts upon the rate of growth of the R10 tumor, administering physiologically standardized amounts. The results were entirely negative.2 The following year, Zondek, Zondek, and Hartoch ( 2 ) showed that excessive doses of prolan, 50 to 200 Aschheim Zondek units per day, produced a ten-fold inhibition in the growth of a mouse carcinoma. Later Gross (3), Wiesner and Haddow (41, and Gruhzit ( 5 ) , all working with different tumors and varied dosage, reported negative results. Studying the tumor utilized by the Zondeks, Moller ( 6 ) and Cannavo ( 7 ) confirmed the Zondek results, showing that more than 1500 Aschheim Zondek units of prolan were necessary to produce the retardation in tumor growth. Krehbiel et a1 ( 8 ) , using a Squibb prolan, found that three-fourths of the mice died on a dose corresponding to that given by the Zondeks, and concluded that under these conditions a retardation in tumor growth of the surviving animals was without significance.
I n the light of present knowledge it is obvious that experimentation with gonadotropic preparations in many applied fields will be unsatisfactory until chemically pure substances have been obtained. It is now controversial whether separable follicular and luteal gonadotropic fractions exist, and their relation to the physiology of the male has not been ascertained (9, 10). Moreover, the rate of liberation at the site of injection has a profound effect upon the physiological activity. Whereas the pituitary preparation produces rapid increments in ovarian weight proportionate with the dosage, the urine of pregnancy preparation in contrast has a shallow dosage curve.:' Extremely large doses of prolan in the present state of purity are apparently toxic to mice (8) and hence tend to invalidate any effects upon tumor growth. Little increase in physiological effect as measured by ovarian changes is manifested by prolan at extremely high dosage levels as compared with moderate doses. Since the addition of pituitary activator to moderate doses of prolan produces effects exceeding those produced by the highest doses of 1 These studies werc made possible by a grant from the International Cancer Research Founda-"orkers (about 10) who later played variations on the same theme apparently overlooked Some confusion doubtless resulted from the fact that some workers did not There is at present no proof that Its physical properties are quite distinct from those of the 3 Ten times the dosc of prolan producing a minimal luteal response doubles the ovarian weight.
Ovarian weight increases are nearly prolan alone, it seemed logical to test the effect of activated prolan upon tumor growth. I n this way maximum physiologic effect without toxic symptoms might be attained. In this paper is presented a study of the effect of massive gonad stimulation through gonadotropic extracts upon two transplanted tumors, R10 and 180. The effect of 2000 units of estrin per mouse upon the growth of tumor 180 is included, as is a preliminary experiment on the effect of prolactin upon the Marsh Buffalo spontaneous mammary carcinoma. 
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EXPERIMENTAL
The technic of inoculation, as well as the method of recording and analyzThe extracts were
Gonudotropic-Prrparatioizs und Estriiz:
The prolan was prepared from The pituitary gonadoing data, was the same as that used in earlier studies ( 11). injected daily at a distance from the site of inoculation.
urine of pregnancy by the method of Marshall ( 1 2 ) .
No. of Mice tropic extracts were prepared by the method of Van Dyke and WallenLawrence (13). No attempt was made to evaluate the prolan in units, since it is generally conceded that no satisfactory method of standardization has been evolved. The effect upon ovarian and seminal vesicle weight was ascertained, however, and these values serve as a measure of the physiological activity of the preparations used. The activator produced a four-fold increase in ovarian weight (160 mg. ovary) over that produced by prolan alone (35 mg. ovary). The estrin was obtained from the ether washings of several lots of urine of pregnancy. Purification was carried out according to the method of Veler, Thayer, and Doisy (14) . The final product was thrown down in semi-crystalline form from dilute alcohol and was suspended in water. The potency as ascertained by standardization upon immature female rats by the method of Doisy indicated a minimum value of 130 units per mouse per day for the material used in the inoculation experiment. Each mouse, therefore, received over 2000 units in fifteen days,
The results (Table I) show that doses of activated prolan and pituitary gonadotropic preparations, which produced as high as 300 per cent increases in the weights of ovaries and seminal vesicles of the cancer-bearing animals, failed to produce changes in tumor growth (mouse sarcoma 180, rat sarcoma R10). Untreated urine of pregnancy which produced a complete arrest of body weight caused also a retardation of tumor growth. In this isolated case other factors beside the prolan in the urine doubtless affected the results.
Estrin in a total dose of 2000 units per mouse failed to affect tumor growth (Table 11) . Under these conditions of massive dosage a decrease in the activity of the male gonads was indicated as judged by decreases in the weights of testes and seminal vesicles.
Prolactin: Since prolactin is one of the hormone-like substances present in pituitary extracts, it seemed important to establish its effect upon tumor growth. Squibb and Co. furnished us with an extract assaying 40 bird units per cubic centimeter. This was administered in daily doses of 4 bird units per mouse for fifteen days to mice bearing spontaneous mammary carcinomas. Successive measurements of the tumors were as given in Table 111 .
No marked effect upon tumor growth is indicated, as compared with the control values (1 1 ). The potency of the extract was re-checked at the time of dosage by tests upon six pigeons. Four doses of 4 units per 150 gm. pigeon produced milk crop glands weighing 1.3 gm. (average) per 150 gm.
